About 20% of HER2+ breast cancers had abnormal CTTN copy numbers and/or expression, and the frequencies for CCND1 were similar, while alterations in the other genes were found at relatively low frequencies (Figure 1A). The gene discussed is CTTN; the disease is breast cancer.